Abstract Background d-Transposition of the great arteries (d-TGA) is a congenital cardiac defect that is typically fatal. Those patients who survive without surgical repair and who are rare in number, need adequate intracardiac shunting and will suffer from chronic cyanosis. Here, we present a rare case of an adult with unrepaired cyanotic congenital heart disease (CHD) who developed infective endocarditis (IE) and also our approach to the medical decision-making process in this uncommonly encountered dilemma. Case summary A 52-year-old female with unrepaired d-TGA with tricuspid atresia, hypoplastic right ventricle, unrestricted atrial septal defect, ventricular septal defect, and sub-valvular as well as valvular pulmonic stenosis with a hypoplastic, bicuspid pulmonary valve presented with abdominal pain and hypoxia and was found to have an acute renal infarct. Transthoracic echocardiogram (TTE) revealed a large mobile mass on the mitral valve. Blood cultures grew Streptococcus mitis-oralis and she was diagnosed with streptococcal native mitral valve IE complicated by a renal embolus. Her large left-sided vegetation and embolic phenomenon favoured surgery. However, a right heart catheterization showed normal intracardiac pressures, likely a result of multi-level obstruction relating to sub-valvular and valvular pulmonary stenosis protecting the pulmonary vasculature from over-circulation and pulmonary hypertension. Cardiac surgery posed a significant risk of destabilizing her delicately balanced haemodynamics. Hence, she was treated with ceftriaxone for 4 weeks. A repeat TTE 8 weeks later showed a resolution of the vegetation. Discussion A decision for surgery vs. medical treatment for IE in adult patients with compensated CHD should be made following a multi-disciplinary assessment of each patient’s unique cardiac haemodynamics and after shared decision-making with the patient.
[1]
G. Diller,et al.
Management considerations in the adult with surgically modified d-transposition of the great arteries
,
2021,
Heart.
[2]
C. Fraser,et al.
Contemporary Outcomes of the Fontan Operation: A Large Single-Institution Cohort.
,
2019,
The Annals of thoracic surgery.
[3]
Stephanie Fuller,et al.
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
,
2019,
Journal of the American College of Cardiology.
[4]
R. Kirby.
The prevalence of selected major birth defects in the United States.
,
2017,
Seminars in perinatology.
[5]
Susanna Price,et al.
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
,
2015,
European heart journal.
[6]
D. Grobbee,et al.
Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population.
,
2011,
European heart journal.
[7]
P. Kirshbom,et al.
The bidirectional Glenn operation: a risk factor analysis for morbidity and mortality.
,
2008,
The Journal of thoracic and cardiovascular surgery.
[8]
M Nakazawa,et al.
Infective endocarditis in congenital heart disease: Japanese national collaboration study
,
2005,
Heart.